{
  "abstract": "Objective To investigate the levels of neutrophil-to-lymphocyte ratio(NLR),monocyte-to-lymphocyte ratio(MLR),and C-reactive protein-to-albumin ratio(CAR)in patients with Crohn's disease treated with ustekinumab,and to evaluate the predictive value of these three individual indicators and their combination for the efficacy of ustekinumab in the treatment of Crohn's disease patients. Methods A retrospective analysis was performed on medical records of 61 patients with Crohn's disease who were treated with ustekinumab at Yijishan Hospital of Wannan Medical University from January 2021 to December 2025. Based on treatment outcomes,18 patients with loss of response were assigned to group A,and 43 patients with effective response were assigned to group B. NLR,MLR,and CAR were compared between the two groups. Receiver operating characteristic(ROC)curves were constructed to assess the predictive value of NLR,MLR,CAR,and their combination for the efficacy of ustekinumab therapy. Results NLR(2.74±1.43 vs 1.79±0.71,t=2.683,P=0.014),MLR(0.30±0.11 vs 0.23±0.06,t=2.546,P=0.016),and CAR［0.31(0.14,0.51)vs 0.05(0.03,0.08),Z=5.134,P<0.01］in group A were significantly higher than those in group B. ROC curve analysis showed that the area under the curve (AUC)for NLR,MLR,and CAR alone in predicting loss of response to ustekinumab were 0.756,0.753,and 0.918,respectively,while the AUC for the combined indicators was 0.970.Conclusion NLR,MLR,and CAR each has certain predictive value for the therapeutic efficacy of ustekinumab in patients with Crohn's disease. The combination of these indicators yields the highest predictive performance and may facilitate early identification of patients with loss of response to ustekinumab therapy.",
  "abstract_shown": true,
  "affiliations": [
    "Department of Gastroenterology,The First Affiliated Hospital(Yijishan Hospital)of Wannan Medical University,Wuhu,Anhui 241001,China"
  ],
  "article_type": null,
  "arxiv": null,
  "author_total": 5,
  "authors": [
    {
      "affs": [
        0
      ],
      "name": "WANG Jing"
    },
    {
      "name": "LI Lin"
    },
    {
      "name": "CHEN Pingbo"
    },
    {
      "name": "HE Chiyi"
    },
    {
      "name": "NIU Xiaoping"
    }
  ],
  "bibtex": "https://research.draconitic.com/paper/72f7bwkemf46s.bib",
  "cited_by": 0,
  "doi": "10.13429/j.cnki.cjcr.2026.10.018",
  "fulltext_url": "http://zglcyj.ijournals.cn/zglcyj/ch/reader/create_pdf.aspx?file_no=20261018",
  "id": "72f7bwkemf46s",
  "issns": [
    "1674-8182"
  ],
  "landing_url": "https://doi.org/10.13429/j.cnki.cjcr.2026.10.018",
  "language": "zh",
  "licence": "CC-BY-NC-ND",
  "licence_label": "CC BY-NC-ND",
  "licence_source": "journal",
  "licence_url": "https://creativecommons.org/licenses/by-nc-nd/4.0/",
  "metadata_licence": null,
  "native_subjects": [
    [
      "lcc",
      "R"
    ],
    [
      "openalex",
      "1311|Inflammatory Bowel Disease"
    ]
  ],
  "openalex": "W7224110671",
  "pdf_url": null,
  "pmcid": null,
  "pmid": null,
  "published": "2026-10-26",
  "publisher": "The Editorial Department of Chinese Journal of Clinical Research",
  "ris": "https://research.draconitic.com/paper/72f7bwkemf46s.ris",
  "sources": [
    {
      "first_seen": "2026-10-30T13:47:14Z",
      "native_id": "adaf3b8ccd1e42889e774e65882f7995",
      "source": "doaj",
      "url": "https://doi.org/10.13429/j.cnki.cjcr.2026.10.018"
    }
  ],
  "subjects": [
    {
      "field": "biology",
      "origin": "openalex:1311|Inflammatory Bowel Disease",
      "subfield": "genetics-genomics"
    }
  ],
  "title": "Predictive value of NLR,MLR and CAR on the efficacy of ustekinumab in patients with Crohn's disease",
  "title_text": "Predictive value of NLR,MLR and CAR on the efficacy of ustekinumab in patients with Crohn's disease",
  "type": "peer-reviewed",
  "updated_at": "2026-10-30T13:47:14Z",
  "url": "https://research.draconitic.com/paper/72f7bwkemf46s",
  "venue": "Zhongguo linchuang yanjiu",
  "versions": []
}